mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.002 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.003 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.003 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.003 |